CLYM · Climb Bio, Inc. · Proposed Sales
$8.87
-0.46 (-4.93%)
At close · Nov 5
Return incl. dividend (before tax)
Market Cap
$521.01M
Shares
58.74M
Volume · Nov 5
1.44M
Avg daily vol (3M)
1.41M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-09-15 | STEPHEN THOMAS | Director | 100,000 | 2026-09-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-06-30 | AOIFE BRENNAN | Officer, Director | 30,902 | 2026-06-29 | E-TRADE FINANCIAL CORPORATION |
| 2026-02-25 | STEPHEN THOMAS | Director | 50,000 | 2026-02-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-12 | STEPHEN THOMAS | Director | 100,000 | 2026-02-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–4 of 4 filings
Key facts
CIK
1768446
CUSIP
28658R106
13F (30d)
30 filings
26 filers
Visit website
Investor relations